Skip to main content
. 2018 Aug 29;15(145):20180472. doi: 10.1098/rsif.2018.0472

Figure 3.

Figure 3.

Crystal structures of de novo inhibitors binding to their targets. Crystal structures of inhibitor complexes. (a) Inhibitor peptide αMCL1 (red) binds the human BCL2 homologue, Mcl-1 (blue), with picomolar affinity [60]. PDB: 5JSB. (b) Inhibitor peptide HB1.6928.2.3 (red), which can bind influenza haemagglutinin [59]. PDB: 5VLI.